ArticleNeuroImage2026
An explainable framework for the relationship between dementia and metabolism patterns.
Article in NeuroImage, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
High-dimensional neuroimaging data poses a challenge for the clinical assessment of neurodegenerative diseases, as it involves complex non-linear relationships that are difficult to disentangle using traditional methods. Variational Autoencoders (VAEs) provide a powerful framework for encoding neuroimaging scans into lower-dimensional latent spaces that capture meaningful disease-related features. In this work, we propose a semi-supervised VAE framework that incorporates a flexible similarity regularization term designed to align selected latent variables with clinical or biomarker measures related to dementia progression. This approach allows adapting the similarity metric and the supervised variables according to specific goals or available data. We demonstrate the framework using Positron Emission Tomography (PET) scans from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database, guiding the model to capture neurodegenerative patterns associated with Alzheimer's Disease (AD) by maximizing the similarity between the first latent dimension with a clinical cognitive score, and the second dimension with age. Leveraging the first supervised latent variable, we generate average reconstructions corresponding to different levels of cognitive impairment. A voxel-wise General Linear Model (GLM) confirms reduced metabolism in key brain regions, predominantly in the hippocampus, and within major Resting State Network (RSN)s, particularly the Default Mode Network (DMN) and the Central Executive Network (CEN). Further examination of the remaining latent variables show that they encode affine transformations-rotation, translation, and scaling-as well as intensity variations, capturing common confounding factors such as inter-subject variability and site-related noise. Our findings indicate that the framework effectively disentangles this neuroimaging biomarker (z
Indexed as
Identifiers
41831541What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.